GlassScriptPhysician profile
John W Bowman
NPI 1093808826
$1,282.09
in general payments reported to CMS, 2019-2025
16 companies · $29.39 in 2025
The $29.39 reported for 2025 was less than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $102 · 2021: $88.90 · 2022: $287 · 2023: $443 · 2024: $143 · 2025: $29.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $615.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $647.84 | 2019-2024 | Oasis, Stravix Pl, Stravix |
| Kci USA, INC. | $120.06 | 2019-2023 | Promogran Prisma, Activ.A.C., Activ.A.C. Ion Progress |
| Abbvie INC. | $111.81 | 2023-2025 | Dalvance |
| Lifenet Health | $108.20 | 2023 | |
| Integra Lifesciences Corporation | $54.62 | 2020-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Progenacare Global, LLC | $37.80 | 2023 | |
| Hartmann USA, INC. | $37.77 | 2020-2021 | |
| Cardinal Health 200 LLC | $30.25 | 2019 | |
| Mimedx Group, INC. | $25.35 | 2024 | |
| Paratek Pharmaceuticals, INC. | $20.34 | 2023 | Nuzyra |
| Urgo Medical North America, LLC | $18.51 | 2024 | Urgok2 |
| Melinta Therapeutics, LLC | $18.17 | 2019 | |
| Tactile Systems Technology INC | $17.46 | 2023 | Flexitouch Plus, Entre Plus |
| Musculoskeletal Transplant Foundation INC. | $13.03 | 2022 | |
| Mckesson Patient Care Solutions INC. | $11.18 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galt Pharmaceuticals, LLC | $9.70 | 2023 | Orphengesic Forte |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bowman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.